Table 1 Demographic, clinicopathological, and laboratory parameters
Demographic, clinicopathological and laboratory parameters | IBD (n=37) | Healthy control (n=14) | p | |
|---|---|---|---|---|
Age | ||||
 ≥ 46.65 years (n=29) | 19 (51.4%) | 10 (71.4%) | >0.05(a) | |
 <46.65 years (n=22) | 18 (48.6%) | 4 (28.6%) | ||
Sex | ||||
 Male (n=30) | 22 (59.5%) | 8 (57.1%) | >0.05(a) | |
 Female (n=21) | 15 (40.5%) | 6 (42.9%) | ||
Hemoglobin†| 19.35 | 43.57 | <0.01(b)** | |
Pathology | ||||
 Active | 6 (16.2%) | — | — | |
 Inactive | 31 (83.8%) | |||
Mayo score | ||||
 1 | 5 (13.5%) | — | — | |
 2 | 2 (5.4%) | |||
 3 | 2 (5.4%) | |||
 4 | 4 (10.8%) | |||
 6 | 15 (40.5%) | |||
 7 | 4(10.8%) | |||
 8 | 2(5.4%) | |||
 9 | 3(8.1%) | |||
Severity | ||||
 Mild | 13 (35.1%) | — | — | |
 Mild to moderate | 21 (56.8%) | |||
 Moderate to severe | 3 (8.1%) |  |  |  |